Send us an emailLonza
COMPANY DETAILS
Muenchensteinerstrasse 38
Basel
4002
Switzerland
HEALTH CATEGORIES
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. As an integrated solutions provider, Lonza is boosting its value creation along and beyond the healthcare continuum with a strong focus on patient healthcare, consumer preventive healthcare and consumer's healthy environment.
Lonza harnesses science and technology to create products that support safer and healthier living and that enhance the overall quality of life. With the recent Capsugel acquisition, Lonza now offers products and services from the custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries.
Benefiting from its regulatory expertise, Lonza is able to transfer its know-how from pharma to hygiene and fast-moving consumer goods all the way to coatings and composites and the preservation and protection of agricultural goods and other natural resources.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 100 sites and offices and approximately 14,500 full-time employees worldwide. The company generated sales of CHF 5.1 billion in 2017 with a CORE EBITDA of CHF 1.3 billion. Further information can be found at www.lonza.com.
Additional Information and Disclaimer
Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.
Certain matters discussed in this news release may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this news release due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this news release.
NUTRITION & HEALTH NEWS
22 Apr 2021 --- Despite – or perhaps because of – the term’s vagueness, naturality demands have a significant presence in the nutrition sphere. They intersect with other on-trend... Read More
NUTRITION & HEALTH NEWS
21 Apr 2021 --- Lonza is releasing an organic addition to its line of UC-II undenatured collagen ingredients, answering what it says is the growing need for the “next generation of joint... Read More
NUTRITION & HEALTH NEWS
20 Apr 2021 --- Throughout the global COVID-19 pandemic, NutritionInsight is dedicated to bringing its readers all the latest and most relevant industry updates. Visit this regularly-updated news... Read More
NUTRITION & HEALTH NEWS
02 Apr 2021 --- In nutrition news this week, Dr. Paul Lohmann’s magnesium citrate malate was approved for food supplement fortification in Europe, and a study gave evidence that processed... Read More
NUTRITION & HEALTH NEWS
26 Mar 2021 --- This week in nutrition news, Arla Foods Ingredients showcased its whey protein fortification product in a fruit juice, while Ireland awarded almost half a million in grants for... Read More
22 Dec 2020 --- General health with an emphasis on digestion is set to reach new heights over the coming years as new research emerges, according to Roel van de Put, Lonza Capsules and Health Ingredients’ business development manager. Beauty-from-within, mobility, mood health and immunity will also be major forces shaping the nutritional realm, he predicts.
02 Jan 2020 --- Lonza launched Vcaps Plus White Opal, its first commercially-available titanium dioxide-free semi-opaque capsule for food supplements, at CPhI Worldwide 2019. The launch precedes a ban on titanium dioxide, set to come into force in France, 2020. Stéphane Vouche, Marketing Manager at Lonza, predicts that increased scrutiny is bound to increase demand for clean label solutions in the space – something the new product offers with its avoidance of unnecessary chemicals, plasticizers and other elements.
14 May 2019 --- At Vitafoods Europe 2019, Lonza launched its new Vcaps Plus White Opal capsule in a bid to address the growing demand for opaque capsules that do not include titanium dioxide. NutritionInsight spoke with Dominik Mattern, Associate Director Business Development, Head of Business Development, Lonza, about the new launch as well as the company's clean label platform.
25 Apr 2019 --- At In-cosmetics Global 2019 in Paris, Lonza exhibited a number of concepts, including SYNETH, a series of polyglycerol esters. Each fiber offers a unique and innovative texture and aesthetic for the personal, intimate, body and oral care spaces. Jennifer Clancy notes that Lonza is offering turn-key solutions in personal care and beauty and providing consumers with a fully holistic view of health and wellness.
11 Feb 2019 --- Lonza recently revealed the global launch of its latest dosage form innovation: Capsugel Vcaps Plus plant-based capsules. The first of the next-generation clean label solutions to be marketed worldwide is the Vcaps Plus Purple Carrot capsule, following the successful introduction of the Vcaps Plus Blue Spirulina capsule in Europe earlier this year. The high-performance capsule shell is made using plant-based hypromellose (HPMC) and water only, without any preservatives. A colorant derived from purple carrots is used to match the desired shade as closely as possible, while maintaining a natural appearance in the finished supplement. Achieving unique visual appeal, the purple carrot color also provides masking capabilities.
THE WORLD OF FOOD INGREDIENTS
18 Aug 2020 --- Key suppliers offer their thoughts on the nutritionals industry. Which formats, flavors, and active ingredients are consumers seeking in “the new normal”?
Consumers are increasingly looking for plant-based offerings and supplements are no exception. Plant-based or vegan claims on supplements grew by 34 percent between 2015 and 2019 and show no... Read More
While differing generations have unique nutritional priorities, they share a desire to live healthy and less stressed lives. This has led many to turn to supplements as an easy way to... Read More
Clean label remains king in the supplement space, as consumers who are wary of ingredient traceability and safety are drawn to shorter label lists. Concerns from consumers and lobby groups... Read More
The aging consumer has growing expectations of bone and joint health solutions, thanks to the mainstreaming of sports nutrition and a growing focus on active aging. According to Innova... Read More
Products featuring bone & joint health claims are on the rise, with Innova Market Insights data showing a compound annual growth rate of 13 percent between 2013 and... Read More
15 Feb 2021 --- During the last week, Evolve BioSystems landed US$55 million for the commercialization of its “next generation of probiotic.” Other top stories include Lonza’s US$4.7 billion sale of its Speciality Ingredients business and Kappa Bioscience’s US expansion of its vitamin K2 production.
25 Jan 2021 --- This week’s NutritionInsight NewsBite podcast looks into e-gaming’s emerging market potential. Recent business news highlights include Lonza’s exit from the softgel arena in the pharma market and other moves in the infant formula sector.
05 Nov 2020 --- For today’s health-conscious and responsible consumers, Lonza’s Capsugel Plantcaps capsules provide the premier balance of product performance and convenience. This webinar dives into the latest market trends, as well as the science and regulatory landscape surrounding Plantcaps.
24 Jun 2020 --- Supplement users increasingly aspire to more sustainable, health-focused ideals and are on the hunt for high-quality, responsibly sourced products that help them to stay mobile and live better. In this webinar, Lonza experts delve into how these preferences extend across a range of emerging, on-demand consumer trends, from joint and cognitive health to probiotics and beauty-from-within.
08 Nov 2019 --- This webinar will discuss how food supplement makers can address the rising consumer demand for clean and clear label solutions in light of the changing regulatory environment regarding the use of titanium dioxide as an opacifier. It will also explore how Lonza’s new Vcaps® Plus WHITE OPAL® capsule is designed to perform and can support producers to meet this growing need in today’s market.
28 Mar 2019 --- The NutritionInsight webinar “Moving with the times: a new generation joint health solution for today’s consumer” offers insights into the changing consumer landscape, including the expectations of both aging and active consumers and rising demand for joint health solutions. Dominik Mattern of Lonza Capsugel discusses the science behind Lonza’s UC-II undenatured type II collagen ingredient, including its unique mode of action and how it can meet the needs of a new and growing consumer base. He presents a first look at Lonza’s new generation of ready-to-market innovative dosage forms and formulations that address mobility concerns related to healthy aging.
19 Oct 2018 --- UC-II® undenatured type II collagen is a once-a-day joint health solution for the joint health market. Its small dose size and mode of action help make it the preferred choice among top food supplement manufacturers and retailers. Learn why UC-II® undenatured type II collagen is a success story and discover new ready-to-market solutions.
